logoTry Persana

Humane Genomics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Humane Genomics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Humane Genomics company logo

Platform to engineer cancer killing viruses using synthetic biology.

Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency, targeting liver cancer.

HeadquartersNew York, United States
Team size1-10
Founded2019

What is Humane Genomics? - Company Overview & Details

Humane Genomics is Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency, targeting liver cancer. Founded in 2019, the company is headquartered in New York, United States.

Who Founded Humane Genomics?

Humane Genomics was founded by Peter Weijmarshausen.

Who are the Key Executives at Humane Genomics? - Leadership Team

Humane Genomics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Humane Genomics

Peter WeijmarshausenCEO

Chief Technology Officer (CTO) of Humane Genomics

CTO

About Peter Weijmarshausen - CEO of Humane Genomics

Peter Weijmarshausen serves as the Chief Executive Officer of Humane Genomics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Humane Genomics Company Details & Key Information

Where is Humane Genomics located?

Humane Genomics is headquartered in New York, United States.

How many employees does Humane Genomics have?

Humane Genomics has 1-10 employees.

When was Humane Genomics founded?

Humane Genomics was founded in 2019.

Humane Genomics Official Website

How much funding has Humane Genomics raised?

Humane Genomics has raised undisclosed amount across 4 funding rounds. The most recent funding was completed on 2025-03-12.

Funding Overview

Humane Genomics has raised funding led by Union Square Ventures to advance their platform for cancer therapies.

N/A
Total Funding Raised
4
Funding Rounds
2025-03-12
Latest Round

Humane Genomics Funding History

Seed
2021-10-14
Seed
2025-03-12

Who are the key investors in Humane Genomics?

Humane Genomics is backed by 1 key investors including Union Square Ventures. These investors focus on Biotechnology, Cancer therapeutics sectors.

Humane Genomics Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of Humane Genomics Investors

Union Square Ventures

Invests at the edge of large markets transformed by technological and societal pressures.

Investment Focus
Biotechnology
Cancer therapeutics

What sectors do Humane Genomics investors focus on?

The investors backing Humane Genomics primarily focus on Biotechnology, Cancer therapeutics sectors.

Biotechnology
Cancer therapeutics

Featured Investor: Union Square Ventures

Union Square Ventures

Invests at the edge of large markets transformed by technological and societal pressures.

Notable Investments:

What are Humane Genomics's future plans?

Humane Genomics Working on GMP manufacturing and preclinical tests to bring therapies to trials.

Humane Genomics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Humane Genomics face?

Humane Genomics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Humane Genomics

1

GMP manufacturing

2

Funding for trials

What opportunities does Humane Genomics have?

Humane Genomics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Humane Genomics

1

Developing new cancer therapies

2

Expanding research collaborations

Humane Genomics Strategic Position Summary

Key Focus Areas

Humane Genomics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Humane Genomics?

Humane Genomics has 2 recent news updates covering key business developments and market activities.

Humane Genomics News Overview

2
Recent Articles
Active
Media Coverage
2025-02-12
Latest Update

What is Humane Genomics in the news for?

Humane Genomics is currently featured in news for Union Square Ventures invests into Humane Genomics Inc in round of funding. and other significant business developments.

Recent News Articles About Humane Genomics

Article 1
2025-02-12

Union Square Ventures invests into Humane Genomics Inc in round of funding.

Humane Genomics Inc has raised funding led by Union Square Ventures to accelerate its mission of creating cancer therapies.

humanegenomics.com
Read News
Article 2
2020-09-08

Humane Genomics Inc is developing potential vaccine for the COVID-19 virus.

Auburn University and Humane Genomics are collaborating to develop a potential COVID-19 vaccine, adapting research from cancer therapies.

wltz.com
Read News

Humane Genomics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Humane Genomics including information about founders, CEO, funding history, investors, headquarters location, and company details. 16 frequently asked questions covering key information about the company.

Humane Genomics Questions & Answers - Company Information

Q1

What is Humane Genomics?

Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency, targeting liver cancer.

Q2

Who founded Humane Genomics?

Humane Genomics was founded by Peter Weijmarshausen.

Q3

Who is the CEO of Humane Genomics?

The CEO of Humane Genomics is Peter Weijmarshausen. You can find more information about them on their LinkedIn profile.

Q4

Who are the investors in Humane Genomics?

Humane Genomics's key investors include Union Square Ventures.

Q5

Where is Humane Genomics headquartered?

Humane Genomics is headquartered in New York, United States.

Q6

When was Humane Genomics founded?

Humane Genomics was founded in 2019.

Q7

How many employees does Humane Genomics have?

Humane Genomics has 1-10 employees.

Q8

What is Humane Genomics's official website?

You can visit Humane Genomics's official website at http://humanegenomics.com.

Q9

What was Humane Genomics's latest funding round?

Humane Genomics's latest funding round was a Seed round completed on 2021-10-14.

Q10

Who is founder?

Peter Weijmarshausen

Q11

What does the company do?

Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency, targeting liver cancer.

Q12

Latest funding date?

2025-03-12

Q13

Who are the investors?

Union Square Ventures

Q14

What are the challenges?

GMP manufacturing Funding for trials

Q15

What are the opportunities?

Developing new cancer therapies Expanding research collaborations

Q16

Latest news?

Humane Genomics Inc has raised funding led by Union Square Ventures to accelerate its mission of creating cancer therapies. Auburn University and Humane Genomics are collaborating to develop a potential COVID-19 vaccine, adapting research from cancer therapies.

More Information About Humane Genomics

For additional details about Humane Genomics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.